Hemoccult ICT Patient Screening Kits


(40 Patient Screening Kits)

Hemoccult ICT is the latest and most advanced fecal occult blood test (FOBT) in the Hemoccult product line. An immunochemical FOBT (iFOBT) with high specificity and sensitivity, Hemoccult ICT is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult ICT is an ideal screening tool for colorectal cancer (CRC), and this specificity also reduces the number of false positive test results. Safe and non invasive, Hemoccult ICT is very patient friendly, as there are no diet or drug restrictions for patients to follow while they are using it, which helps increase patient compliance. (FDA 510K#: K808012) Each patient screening kit includes 1 dispensing envelope, 3 collection cards, 3 applicator sticks, and 1 pouch.

Hemoccult and Hemoccult II are registered trademarks of Beckman Coulter, Inc. SENSA is a registered trademark of SmithKline Diagnostics, Inc.

Request a Quote

Hemoccult ICT has been proven to be one of the highest and most clinical advanced immunochemical tests with high sensitivity and specificity. Immunochemical tests are part of the standard of care and screening program for colorectal cancer screening programs worldwide.


  • For identifying gastrointestinal bleeding
  • Not drug restriction or special dietary concerns
  • Now available in convenient 2 or 3 day patient collection kits
  • All slides stable for 14 days
  • FDA Cleared and CLIA waived

CPT Code*

  • G0328QW - Fecal blood scrn immunoassay
    • National Average Reimbursement 2019: $18.05
  • 82274QW - Assay test for blood fecal
    • National Average Reimbursement 2019: $17.67

*All CPT codes are supplied for information purposes only and represent no statement; promise or guarantee by CLIAwaived Inc. that these codes will be appropriate or that reimbursement will be made. It is the responsibility of the service provider to confirm the appropriate coding required by their local Medicare carriers, fiscal intermediaries and commercial payors.


Hemoccult and Hemoccult II are registered trademarks of Beckman Coulter, Inc. SENSA is a registered trademark of SmithKline Diagnostics, Inc.

© 2020 Cliawaived, Inc. All Rights Reserved. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.